Home › Bronchial Cancer › Virginia › Arlington
Bronchial Cancer clinical trials in Arlington, VA
3 studies for Bronchial Cancer are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi away
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- USO - Virginia Cancer Specialists, Fairfax · 11 mi away
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
RecruitingPhase 3
- Virginia Cancer Specialists, Fairfax · 11 mi away
Bronchial Cancer trials in other cities
- New York City, NY6 studies
- Houston, TX5 studies
- Boston, MA4 studies
- Pittsburgh, PA4 studies
- Columbus, OH4 studies
- Tampa, FL3 studies
- Indianapolis, IN3 studies
- Minneapolis, MN3 studies
- Miami, FL3 studies
- Memphis, TN3 studies
- Cincinnati, OH3 studies
- Chicago, IL3 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)48 studies
- Ovarian Cancer46 studies
- Breast Cancer46 studies
- Lung Cancer40 studies
- Endometrial Cancer39 studies
- Pancreatic Cancer34 studies
- Head and Neck Squamous Cell Carcinoma26 studies
- Small Cell Lung Cancer23 studies
- Melanoma20 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.